These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30720577)

  • 21. Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
    Swaisland H; Plummer R; So K; Garnett S; Bannister W; Fabre MA; Dota C; Fielding A
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):775-84. PubMed ID: 27553432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
    Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
    Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations.
    Buffery PJ; Strother RM
    N Z Med J; 2015 Jun; 128(1416):66-74. PubMed ID: 26117678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of QTc Interval Prolongation Associated With Circulating Anti-Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study.
    Lazzerini PE; Cevenini G; Qu YS; Fabris F; El-Sherif N; Acampa M; Cartocci A; Laghi-Pasini F; Capecchi PL; Boutjdir M; Lazaro D
    J Am Heart Assoc; 2021 Feb; 10(4):e018735. PubMed ID: 33533258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-Induced QTc Prolongation.
    Riad FS; Davis AM; Moranville MP; Beshai JF
    Am J Cardiol; 2017 Jan; 119(2):280-283. PubMed ID: 28126150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipsychotic drugs and QT interval prolongation.
    Zareba W; Lin DA
    Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world implications of QT prolongation in patients receiving voriconazole and amiodarone.
    Mourad A; Stiber JA; Perfect JR; Johnson MD
    J Antimicrob Chemother; 2019 Jan; 74(1):228-233. PubMed ID: 30295798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gefitinib Increases the Incidence of QT Prolongation in Patients with Non-Small Cell Lung Cancer.
    Maimaitituersun G; Abulimiti B; Jin M; Dong X; Fu Z
    Int Heart J; 2023; 64(3):365-373. PubMed ID: 37258113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for QTc interval prolongation.
    Heemskerk CPM; Pereboom M; van Stralen K; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
    Eur J Clin Pharmacol; 2018 Feb; 74(2):183-191. PubMed ID: 29167918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced QTc-interval prolongation in the intensive care unit: incidence and predictors.
    Ng TM; Olsen KM; McCartan MA; Puumala SE; Speidel KM; Miller MA; Sears TD
    J Pharm Pract; 2010 Feb; 23(1):19-24. PubMed ID: 21507789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review.
    Porta-Sánchez A; Gilbert C; Spears D; Amir E; Chan J; Nanthakumar K; Thavendiranathan P
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29217664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study.
    van der Sijs H; Kowlesar R; Klootwijk AP; Nelwan SP; Vulto AG; van Gelder T
    Br J Clin Pharmacol; 2009 Mar; 67(3):347-54. PubMed ID: 19523015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of liver transplantation on QT-interval prolongation and impact on mortality.
    Ko J; Koshy AN; Han HC; Weinberg L; Gow P; Testro A; Lim HS; Farouque O; Teh AW
    Int J Cardiol; 2021 Mar; 326():158-163. PubMed ID: 33186663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors.
    Abu Rmilah AA; Lin G; Begna KH; Friedman PA; Herrmann J
    Int J Cancer; 2020 Dec; 147(11):3160-3167. PubMed ID: 32449208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers.
    Kannankeril PJ; Norris KJ; Carter S; Roden DM
    Heart Rhythm; 2011 Oct; 8(10):1530-4. PubMed ID: 21420510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Domperidone and sudden death.
    Prescrire Int; 2006 Dec; 15(86):226. PubMed ID: 17167933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs and ventricular repolarization in a general population: the Rotterdam Study.
    Niemeijer MN; van den Berg ME; Franco OH; Hofman A; Kors JA; Stricker BH; Eijgelsheim M; Rijnbeek PR
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1036-41. PubMed ID: 26248883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Domperidone and long QT syndrome.
    Rossi M; Giorgi G
    Curr Drug Saf; 2010 Jul; 5(3):257-62. PubMed ID: 20394569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.